An Effectiveness-implementation Hybrid Study of Social Prescribing in a Singapore Community Hospital Setting
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04840420|
Recruitment Status : Not yet recruiting
First Posted : April 12, 2021
Last Update Posted : April 12, 2021
This research is an effectiveness-implementation hybrid study with two aims:
1) to determine the utility of a WBC (Well Being Coordinator)-driven Social Prescribing model in the intermediate care setting;
and 2) to assess the patient health outcomes associated with the implementation pilot.
The implementation research questions include:
- Practical fit: Does the intervention fit with the daily life activities of study participants? What is the level of safety and burdensomeness of the frequency, intensity and duration of the intervention?
- Acceptability: What are the acceptance, retention and follow-up rates as the participants move through the intervention? What are the reasons for retention?
- Adoption: How well do the WBC carry out the assessment and intervention as planned?
The key hypotheses include:
- Participants in the intervention group will incur a higher improvement in perceived general wellbeing and social support than those participants in the control group.
- Participants in the intervention group will incur less healthcare utilisation than those in the control group.
- Improvement in the perceived general wellbeing and social support will be moderated by the level of social support of participants.
|Condition or disease||Intervention/treatment||Phase|
|Social Isolation||Other: social prescribing Other: usual care||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||804 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||open label randomised control trial|
|Masking:||None (Open Label)|
|Official Title:||An Effectiveness-implementation Hybrid Study of Social Prescribing in a Singapore Community Hospital Setting|
|Estimated Study Start Date :||April 19, 2021|
|Estimated Primary Completion Date :||September 30, 2022|
|Estimated Study Completion Date :||September 30, 2022|
Active Comparator: Intervention
The WBCs conducts approximately daily visits to:
About 1-week post-discharge, the WBCs will call to check his/her transition back to community and readiness to start attending community activities or receiving services. For community activities, the WBCs and CNS will visit the participant, accompanying him/her to the activity premise on the first day of the activity session and send the participant home after the session.
Other: social prescribing
Inpatient phase For the control group, the interviewer will conduct approximately 2 visits to collect demographics and baseline data. The duration of each visit will range from 15 to 30 minutes.
Community phase For the control group, no intervention will be administered.
Other: usual care
- BIT score [ Time Frame: 2 months post discharge ]general wellbeing measured by the Brief Inventory of Thriving (BIT),
- mMOS-SS score [ Time Frame: 2 months post discharge ]
social support will be measured by the modified Medical Outcomes Study
- Social Support Survey (mMOS-SS)
- healthcare utilisation 12months post enrollment [ Time Frame: 12 months post enrollment ]The participants' health utilisation will include the polyclinic visit, emergency department visit, Specialist Outpatient Clinic (SOC) visit, unplanned admission and average length of stay.
- MBI [ Time Frame: 1 day to 6 months post enrollment ]Modified Barthel Index on discharge
- qualitative study [ Time Frame: 1 day to 12 months post enrollment ]Qualitative semi-structured interviews to understand the experience of participants (in the intervention group)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04840420
|Contact: Wong Peng Yong, Andrew, MBBSemail@example.com|
|Contact: Png Shi Hui, Noelle||+6569307048|
|Principal Investigator:||Lee Kheng Hock, MBBS||Bright Vision Hospital|
|Study Director:||Low Sher Guan, MBBS||Sengkang Community Hospital|
|Study Director:||Low Lian Leng, MBBS||Outram Community Hospital|
|Study Director:||Kwan Li Feng, Adeline||Sengkang Community Hospital|
|Study Director:||Zhao Dan||Sengkang Community Hospital|
|Study Director:||Wong Peng Yong, Andrew, MBBS||Bright Vision Hospital|